Stephen Rundlett

Stephen Rundlett is currently the Vice President of Bioanalysis at Precision For Medicine, where Stephen leads the development and validation of innovative BioAnalytical methods for various compounds. Previously, Stephen served as the Scientific Director at Intertek Pharmaceutical Services, overseeing Bioanalytical programs for Large Molecule PK, ADA, and Biomarkers. Stephen also held roles at Eurofins Bioanalytical Services, EMD Millipore, and UCLA, with a strong background in protein chemistry and biochemistry. With a Ph.D. in Molecular and Cellular Biology from the University of Arizona, Stephen has a wealth of experience in the pharmaceutical and biotechnology industry.